
Eyal has been with the company since its inception and advises the team on sustainable investment and growth strategies. He is an accomplished executive with broad experience in technology, healthcare, finance, investment, strategic growth and portfolio company management. He has served as a director in investment firms specializing and investing in the healthcare, technology industrial and clean technology market segments and he is a board member of a maternal telehealth company. Eyal also served as Chief Operating Officer for a behavioral healthcare company and for a group of bariatric surgery practices as well as served as director of corporate development at leading healthcare companies such as Vantage Oncology (now a part of McKesson), which owns and operates over 50 cancer treatment facilities in 14 states. Education: MBA in Finance, Columbia Business School